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Leukocyte adhesion deficiency type 1 (LAD-1) is an autosomal recessive 
immunodeficiency caused by mutations in the 2 integrin, CD18, and characterized by 
recurrent bacterial infections, impaired pus formation, and delayed wound healing.1 Recent 
studies of CD18 knockout mice have demonstrated that defective migration of neutrophils 
into wound sites causes a severe reduction of transforming growth factor-1 secretion by 
monocytes, resulting in impaired myofibroblast differentiation and delayed wound healing.2 
However, little is known about cellular events of wound healing in human LAD-1. Here, 
we described 3-month-old boy affected with LAD-1 who showed the complete lack of 
CD18 and its associated molecules CD11b and CD11c on his granulocytes and monocytes. 
His immunological and sequencing data have been reported elsewhere.3 He showed delayed 
wound healing after surgical excision of an infected urachal cyst from the age of 2 months 
(Figure A). Similar to the findings of CD18 knockout mice, his wound specimens obtained 
from the surgical debridement revealed the absence of neutrophils and the presence of 
monocyte/macrophage infiltrates (Figure B, C). The infiltrating cells also included low 
numbers of plasma cells as well as lymphocytes, most of which were CD20+ B cells by 
immunohistochemical staining (Figure D). Although our patient showed somatic revertant 
mosaicism within the CD8+ T-cell subset,3 CD18+ cells were not detectable in the wound. 
These findings suggest that 2 integrin-independent mechanisms may play a role in 
transmigration of monocytes and B cells through vascular endothelium. In addition, like 
CD18 knockout mice, the local injection of recombinant transforming growth factor-1 
could be a potential therapy for delayed wound healing. Improved understanding of 
physiology of cutaneous wound healing in LAD-1 may lead to better therapeutic approach 
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Figure. Delayed wound healing that was located just below the umbilicus (A). Wound 
specimens were stained with May-Giemsa (B) or anti-CD68 antibody (C). The percentage 
of cells in wound specimens is shown (D). 
 
 
 
 
